Medication effectiveness concerns
Circulating and -cell MOTS-c levels are low in patients with T2D, and systemic MOTS-c treatment prevents pancreatic islet senescence in S961-treated C57BL/6 mice Mitochondrial functions, such as mitochondrial metabolism, ATP or the production of mitochondrial-derived peptides, decline with aging in mice and in patients with T2D 6,8,9,57,58,59,60,61,62,63,64,65,66,67,68,69
Commercial insurance still varies: coverage is common for type 2 diabetes, less consistent for weight loss alone
A healthcare provider can assess your symptoms, evaluate potential contributing factors, and address any concerns or underlying issues effectively
If you have chronic kidney disease or cardiovascular disease, you may need a lower dose
While the side effects listed on the Ozempic patient leaflet do not list menstrual changes, it can have an indirect effect on period changes